Queenie Jang reveals how the ISCT created an interactive virtual conference in under two months.

Cell and gene therapies are now considered mainstream therapeutic modalities – with revolutionary potential. But that hasn’t always been the case…

What challenges and opportunities do immunotherapy developers face?

The UK’s medicines regulator releases new guidance for Brexit.

Joslin Diabetes Center researchers take the first steps towards an autologous cell therapy for obesity.

What's new in business?

The industry must overcome enormous challenges in order to take the next steps in induced pluripotent stem cell technology.

How can we reduce animal testing in quality control procedures?

How to drive antibody drug development and manufacture forward safely and quickly.

When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.